Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="HERBRECHT, R" or (type any "bookEditor issueEditor" and editor="HERBRECHT, R")

Add to list
Diagnosis and management of Aspergillus diseases : executive summary of the 2017 ESCMID-ECMM-ERS guideline

AJ Ullmann, JM Aguado, S Arikan-Akdagli, DW Denning, AH Groll, K Lagrou, C Lass-Flörl, RE Lewis, P Munoz, PE Verweij, et al.

(2018) CLINICAL MICROBIOLOGY AND INFECTION. 24(suppl. 1). p.e1-e38
Add to list
Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

G Hess, R Herbrecht, J Romaguera, G Verhoef, M Crump, C Gisselbrecht, A Laurell, Fritz Offner (UGent) , A Strahs, A Berkenblit, et al.

(2009) JOURNAL OF CLINICAL ONCOLOGY. 27(23). p.3822-3829
Add to list
- Journal Article
- A1
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

S CHOQUET, V LEBLOND, R HERBRECHT, G SOCIE, AM STOPPA, P VANDENBERGHE, A FISCHER, F MORSCHHAUSER, G SALLES, W FEREMANS, et al.

(2006) BLOOD. 107(8). p.3053-3057
Add to list
- Journal Article
- A1
ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma

F REYES, E LEPAGE, G GANEM, TJ MOLINA, P BRICE, B COIFFIER, P MOREL, C FERME, A BOSLY, P LEDERLIN, et al.

(2005) NEW ENGLAND JOURNAL OF MEDICINE. 352(12). p.1197-1205
Add to list
- Journal Article
- A1
Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B

Fritz Offner (UGent) , V KRCMERY, M BOOGAERTS, C DOYEN, D ENGELHARD, P RIBAUD, C CORDONNIER, B DE PAUW, S DURRANT, JP MARIE, et al.

(2004) ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 48(12). p.4808-4812

Academic Bibliography

Diagnosis and management of Aspergillus diseases : executive summary of the 2017 ESCMID-ECMM-ERS guideline

Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma

Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B

Contents

Support

Contact